New Findings on Autoimmune Etiology of Idiopathic Granulomatous Mastitis: Serum IL-17, IL-22 and IL-23 Levels of Patients

References

• Diesing D, Axt-Fliedner R, Hornung D, et al. Granulomatous mastitis. Arch Gynecol Obstet. 2004;269(4):233–236. doi:10.1007/s00404-003-0561-2.
   PubMedGoogle Scholar
• Wang J, Xu H, Li Z, et al. Pathogens in patients with granulomatous lobular mastitis. Int J Infect Dis. 2019;81:123–127. doi:10.1016/j.ijid.2019.01.034.
   PubMed Web of Science ®Google Scholar
• Sheybani F, Naderi HR, Gharib M, et al. Idiopathic granulomatous mastitis: Long-discussed but yet-to-be-known. Autoimmunity. 2016;49(4):236–239. doi:10.3109/08916934.2016.1138221.
   PubMed Web of Science ®Google Scholar
• Baslaim MM, Khayat HA, Al-Amoudi SA. Idiopathic granulomatous mastitis: A heterogeneous disease with variable clinical presentation. World J Surg. 2007; 31(8):1677–1681. doi:10.1007/s00268-007-9116-1.
   PubMed Web of Science ®Google Scholar
• Martinez-Ramos D, Simon-Monterde L, Suelves-Piqueres C, et al. Idiopathic granulomatous mastitis: A systematic review of 3060 patients. Breast J. 2019;25(6):1245–1250. doi:10.1111/tbj.13446.
   PubMed Web of Science ®Google Scholar
• Salesi M, Karimifar M, Salimi F, et al. A case of granulomatous mastitis with erythema nodosum and arthritis. Rheumatol Int. 2011;31(8):1093–1095. doi:10.1007/s00296-009-1273-0.
   PubMed Web of Science ®Google Scholar
• Bes C, Soy M, Vardi S, et al. Erythema nodosum associated with granulomatous mastitis: report of two cases. Rheumatol Int. 2010;30(11):1523–1525. doi:10.1007/s00296-009-1109-y.
   PubMed Web of Science ®Google Scholar
• Grant CR, Liberal R, Holder BS, Cardone J, et al. Dysfunctional CD39(POS) regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis. Hepatology. 2014;59(3):1007–1015. doi:10.1002/hep.26583.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Zhang Z, Luan Y, et al. Pathological functions of interleukin-22 in chronic liver inflammation and fibrosis with hepatitis B virus infection by promoting T helper 17 cell recruitment. Hepatology. 2014;59(4):1331–1342. doi:10.1002/hep.26916.
   PubMed Web of Science ®Google Scholar
• Naik S. The human HLA system. J Indian Rheumatol Assoc. 2003;11:79–83.
   Google Scholar
• Wilson AG, Duff GW. Genetic traits in common diseases. BMJ. 1995;310(6993):1482–1483. doi:10.1136/bmj.310.6993.1482.
   PubMed Web of Science ®Google Scholar
• Barreto DS, Sedgwick EL, Nagi CS, et al. Granulomatous mastitis: etiology, imaging, pathology, treatment, and clinical findings. Breast Cancer Res Treat. 2018;171(3):527–534. doi:10.1007/s10549-018-4870-3.
   PubMed Web of Science ®Google Scholar
• Wolfrum A, Kümmel S, Theuerkauf I, et al. Granulomatous mastitis: A therapeutic and diagnostic challenge. Breast Care. 2018;13(6):413–418. doi:10.1159/000495146.
   PubMed Web of Science ®Google Scholar
• Altintoprak F, Kivilcim T, Ozkan OV. Aetiology of idiopathic granulomatous mastitis. World J Clin Cases. 2014;2(12):852–858. doi:10.12998/wjcc.v2.i12.852.
   PubMed Web of Science ®Google Scholar
• Benson JR, Dumitru D. Idiopathic granulomatous mastitis: presentation, investigation and management. Future Oncol. 2016;12(11):1381–1394. doi:10.2217/fon-2015-0038.
   PubMed Web of Science ®Google Scholar
• Erhan Y, Veral A, Kara E, et al. A clinicopathologic study of a rare clinical entity mimicking breast carcinoma: idiopathic granulomatous mastitis. Breast. 2000;9(1):52–56. doi:10.1054/brst.1999.0072.
   PubMed Web of Science ®Google Scholar
• Altintoprak F, Karakece E, Kivilcim T, et al. Idiopathic granulomatous mastitis: an autoimmune disease? Sci World J. 2013;4:148727. doi:10.1155/2013/148727.
   Web of Science ®Google Scholar
• Ozel L, Unal A, Unal E, et al. Granulomatous mastitis: is it an autoimmune disease? Diagnostic and therapeutic dilemmas. Surg Today. 2012;42(8):729–733. doi:10.1007/s00595-011-0046-z.
   PubMed Web of Science ®Google Scholar
• Asoglu O, Ozmen V, Karanlik H, et al. Feasibility of surgical management in patients with granulomatous mastitis. Breast J.. 2005;11(2):108–114. doi:10.1111/j.1075-122X.2005.21576.x.
   PubMed Web of Science ®Google Scholar
• Yigitbasi MR, Guntas G, Atak T, et al. The role of interleukin-33 as an inflammatory marker in differential diagnosis of idiopathic granulomatous mastitis and breast cancer. J Invest Surg. 2017;30(4):272–276. doi:10.1080/08941939.2016.1240270.
   PubMed Web of Science ®Google Scholar
• Dai H, He F, Tsokos GC, et al. IL-23 limits the production of IL-2 and promotes autoimmunity in lupus. J Immunol. 2017;199(3):903–910. doi:10.4049/jimmunol.1700418.
   PubMed Web of Science ®Google Scholar
• Kyttaris VC, Zhang Z, Kuchroo VK, et al. Cutting edge: IL-23 receptor deficiency prevents the development of lupus nephritis in C57BL/6-lpr/lpr mice. J Immunol. 2010;184(9):4605–4609. doi:10.4049/jimmunol.0903595.
   PubMed Web of Science ®Google Scholar
• Paradowska-Gorycka A, Grzybowska-Kowalczyk A, Wojtecka-Lukasik E, et al. IL-23 in the pathogenesis of rheumatoid arthritis. Scand J Immunol. 2010;71(3):134–145. doi:10.1111/j.1365-3083.2009.02361.x.
   PubMed Web of Science ®Google Scholar
• Murthy A, Shao YW, Defamie V, et al. Stromal TIMP3 regulates liver lymphocyte populations and provides protection against Th1 T cell-driven autoimmune hepatitis. J Immunol. 2012;188(6):2876–2883. doi:10.4049/jimmunol.1102199.
   PubMed Web of Science ®Google Scholar
• Longhi MS, Liberal R, Holder B, et al. Inhibition of interleukin-17 promotes differentiation of CD25-cells into stable T regulatory cells in patients with autoimmune hepatitis. Gastroenterology. 2012;142(7):1526–1535.e6. doi:10.1053/j.gastro.2012.02.041.
   PubMed Web of Science ®Google Scholar
• Sun D, Lin Y, Hong J, et al. Th22 cells control colon tumorigenesis through STAT3 and polycomb repression complex 2 signaling. Oncoimmunology. 2016;5(8):e1082704. doi:10.1080/2162402X.2015.1082704.
   PubMed Web of Science ®Google Scholar
• Chen DY, Chen YM, Chen HH, Hsieh CW, et al. Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-α therapy. Arthritis Res Ther. 2011;13(4):R126. doi:10.1186/ar3431.
   PubMed Web of Science ®Google Scholar